<< MMI partners with Surgitech Medical Sales to expand sales distribution team | Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Gamma Pharmaceuticals inks brokerage agreement with J&A Lazier Racing

Published on October 28, 2009 at 10:18 AM · No Comments

Gamma Pharmaceuticals Inc. (the "Company") (PINKSHEETS: GMPM) announced it has signed a Product Brokerage Agreement with J&A Lazier Racing LLC of California. Mr. Lazier, an accomplished Indy Car Driver, will benefit from Gamma's Professional Grade vitamin supplements, nutritional and energy products to ensure peak athletic performance during the demanding Indy Car season. Gamma will make the products developed for the Indy Car race conditions available to consumers worldwide through Gamma's global distribution platform.

Peter Cunningham, Gamma's CEO, stated, "We are thrilled to be in business with such an elite global athlete and personality. Gamma will be Mr. Lazier's off-track pit crew. The objective is to keep Mr. Lazier in peak performance condition for the Indy Car season."

The Product Brokerage Agreement supports Gamma's entry into the world of Indy Car Racing. Indy Car Racing is the premier motor sport in the US with a substantial domestic and global following. The sport fits Gamma's global identity and up-market brand profile. The Indianapolis 500 is the largest single day sporting event in the world, attracting nearly 150 million television viewers and approximately 500,000 spectators. Gamma has built a full promotional and marketing program designed to attract motor sports fans to Gamma's branded products.

SOURCE: Gamma Pharmaceuticals Inc.

Posted in:

Tags: , , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading